The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens.
about
Insights into Bacteriophage Application in Controlling Vibrio SpeciesGenetically Engineered Phages: a Review of Advances over the Last DecadeBiocontrol and Rapid Detection of Food-Borne Pathogens Using Bacteriophages and EndolysinsPhage cocktails and the future of phage therapyGlobal Epidemiology of Campylobacter InfectionColonisation of a phage susceptible Campylobacter jejuni population in two phage positive broiler flocksStrain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of InfectionControl of campylobacter in poultry industry from farm to poultry processing unit: A review.Campylobacter bacteriophages and bacteriophage therapy.Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages.A suggested classification for two groups of Campylobacter myoviruses.Reservoir of bacterial exotoxin genes in the environment.Microplate-test for the rapid determination of bacteriophage-susceptibility of Campylobacter isolates-development and validationReduction of Campylobacter jejuni in broiler chicken by successive application of group II and group III phages.Primary isolation strain determines both phage type and receptors recognised by Campylobacter jejuni bacteriophagesImpact of a single phage and a phage cocktail application in broilers on reduction of Campylobacter jejuni and development of resistanceCampylobacter jejuni group III phage CP81 contains many T4-like genes without belonging to the T4-type phage group: implications for the evolution of T4 phages.Campylobacter spp. as a Foodborne Pathogen: A ReviewBacteriophage F336 recognizes the capsular phosphoramidate modification of Campylobacter jejuni NCTC11168Genome and proteome of Campylobacter jejuni bacteriophage NCTC 12673Campylobacter group II phage CP21 is the prototype of a new subgroup revealing a distinct modular genome organization and host specificity.The genome and proteome of a Campylobacter coli bacteriophage vB_CcoM-IBB_35 reveal unusual features.Campylobacters and their bacteriophages from chicken liver: The prospect for phage biocontrol.Bacteriophage biocontrol of foodborne pathogensBack to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1The Minor Flagellin of Campylobacter jejuni (FlaB) Confers Defensive Properties against Bacteriophage InfectionGenetically manipulated phages with improved pH resistance for oral administration in veterinary medicine.Evaluation of the efficacy of chitosan nanoparticles loaded ΦKAZ14 bacteriophage in the biological control of colibacillosis in chickens.Alternative therapies for Helicobacter pylori: probiotics and phytomedicine.Prevention of bacterial foodborne disease using nanobiotechnology.Use of encapsulated bacteriophages to enhance farm to fork food safety.Control strategies against Campylobacter at the poultry production level: biosecurity measures, feed additives and vaccination.Impact of human Campylobacter infections in South-East Asia: the contribution of the poultry sector.Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.Bacteriophages: The possible solution to treat pathogenic bacteria.Physiological and Molecular Characterization of Salmonella Bacteriophages Previously Used in Phage Therapy.Characterization of a novel bacteriophage, Phda1, infecting the histamine-producing Photobacterium damselae subsp. damselae.Bacteriophage therapy to combat bacterial infections in poultry.Bacteriophages and their role in food safety.The complete genome sequence of bacteriophage CP21 reveals modular shuffling in Campylobacter group II phages.
P2860
Q26739744-5CC659B7-78F4-496F-A3B3-EDC55A84B944Q26744156-61A9C9B3-348B-44AC-B631-0CC280A059AFQ26752523-DD2B23D6-22FB-4283-9CB9-CA79C07B7D5DQ26995797-CF0D1736-72D2-4D1D-AB8A-B15A6A24A44DQ28396111-ABCCF8D3-B716-4589-8AF8-ED76CCCF6947Q28537874-C7D2F821-6B64-4D09-89E8-60F235395CB4Q28546694-F432C01B-1C63-4D71-A1FC-9572ED0EE626Q30252159-7160AFB5-824B-438D-BA97-8B4C78D6A188Q34174080-1F3DE3E4-DEF8-4237-9833-848CC42B637EQ34296269-48308DE7-5C59-4015-9AE9-AFBD11E15018Q34359519-2A20B556-89E9-4B04-B64C-8DF1A85D2633Q34521272-90223615-E860-401A-8992-A3E3C5935E5EQ34562421-C055006D-F21A-4889-BA35-39733A971E97Q34663447-9F249425-50E1-4C6B-B21D-3FDA920942FAQ34942249-9327EC82-55E3-4703-BA2D-31E42FB25D1CQ35036500-ED51150A-891C-4C2D-B0A2-BB3EABF1810DQ35193011-A5BC36B1-BE7B-43D7-848B-CD218663DC3FQ35233632-40076000-71DC-4661-B517-7799F425A0E9Q35598730-4638D9C4-DBE9-40E3-98C5-57D53FFC9EE4Q35599165-F33FBB79-E59C-4D70-8359-892463BE5CBAQ35752715-C3749071-B014-4C2B-B5F5-2E6EFB528174Q35878208-3E8B297B-A794-4DCE-852D-CF223C55E1DBQ36114497-86752389-435B-45FC-8DD2-8E613715CC0AQ37174605-ECD0618E-5378-460B-A8AF-EBFC82DC85F9Q37244657-AB562B78-F285-401F-8BA7-A1DBC60B35E0Q37447180-1DA7E31E-AB08-4D1A-BF3E-D66D5D930084Q37504784-C474FB04-386C-46EF-9062-64CF7F9C7FE0Q37606227-93E8093B-8F5A-4729-9ECF-5AD7621D8611Q37955181-7D0E39A7-77A8-4DA3-AE24-30622572D2C7Q38253621-2102CE4D-C6DB-4ECE-B216-09E06F31FA8FQ38584325-27FED61C-7BC6-473B-A359-07BAF5DB6195Q38626191-3D008D02-3F53-41C7-BFC7-6A5ABA68E1BFQ38779817-C2D94209-5AEF-4AC5-8489-16BC0D6F3A7FQ39023156-AB4AA05E-C4B6-4BC1-B248-174E591A3BE0Q40070554-F1A2373B-F854-4C46-AE66-9F139899C18EQ40267322-F98FDA3D-2BFD-4CBE-A64B-ADC39FCA59BAQ41158620-1FEBB422-ACF4-4D17-B846-A4F88E9060B6Q41718786-F05D2A9B-DBBA-4BD4-A83D-3E53C47EE92AQ42029552-9FDDFAA8-5292-4A9F-B92E-C23331C9AE33Q42085233-21A77B19-02EB-45FE-94DB-D0E452FB4AF1
P2860
The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The in vivo efficacy of two ad ...... pylobacter jejuni in chickens.
@ast
The in vivo efficacy of two ad ...... pylobacter jejuni in chickens.
@en
type
label
The in vivo efficacy of two ad ...... pylobacter jejuni in chickens.
@ast
The in vivo efficacy of two ad ...... pylobacter jejuni in chickens.
@en
prefLabel
The in vivo efficacy of two ad ...... pylobacter jejuni in chickens.
@ast
The in vivo efficacy of two ad ...... pylobacter jejuni in chickens.
@en
P2093
P2860
P356
P1433
P1476
The in vivo efficacy of two ad ...... pylobacter jejuni in chickens.
@en
P2093
Ben W Gannon
Carla M Carvalho
Christine M Hayes
Deborah E Halfhide
Joana Azeredo
John M Roe
Silvio B Santos
P2860
P2888
P356
10.1186/1471-2180-10-232
P577
2010-09-01T00:00:00Z
P5875
P6179
1021990367